Business Wire

CEGID

24.4.2024 15:37:29 CEST | Business Wire | Press release

Share
EBP Shareholders Enter into Exclusive Negotiations with Cegid to Create a European Leader in the Highly Strategic and Growing Market for Micro and SMB Enterprise Software

Cegid, a European leader in cloud business management solutions for finance (treasury, tax, ERP), human resources (payroll, talent management), CPAs, retail and entrepreneurial sectors, strengthens its position in the fast-growing sector of invoicing and accounting software solutions for the Micro and SMB segments through the potential acquisition of EBP, one of the leading enterprise software providers in this market segment. Following Cegid’s investments in Iberia and Belgium, this major step will allow the new Cegid Group to become the leader in this high-growth market segment ahead of the implementation of mandatory e-invoicing.

EBP, established as one of the leading solutions providers in France known for its long-standing expertise in working with Micro and SMB businesses, its user-centered approach and its distinctive know-how, has been serving its customer base of 275,000 companies using its solutions in France for close to 40 years.

The acquisition of EBP represents a major strategic milestone for Cegid, enabling Cegid to extend its offering with a range of invoicing, business management and accounting software tailored to meet the needs of Micro and SMB businesses in France, including in specific verticals such as construction and automotive. With its existing footprint in Iberia and Belgium, this opportunity also allows Cegid to strengthen its European leadership with this new position in the French market.

With the acquisition of EBP, we are accelerating our European strategy in serving small businesses, one of Cegid’s five priority markets. By combining our two companies, EBP and Cegid, we become a leader with annual revenue close to one billion euros and serving close to 750,000 customers. Our shared vision, the strength of our two brands, the performance of the combined product portfolio, our innovation in emerging technologies such as artificial intelligence, our culture centered around co-creation and entrepreneurship, and the talent within our teams create a unique opportunity. Through this collaboration, we will meet the needs of small businesses directly or through the network of 440 partners built by EBP; most importantly, we will enable chartered accountants to strengthen their strategic position with French Micro and SMB businesses by offering them a wide range of innovative and purposeful business solutions. Cegid will thus become the software provider of choice for Micro and SMBs, supporting the digitalisation of the economy by facilitating compliance in a changing regulatory landscape including the advent of mandatory electronic invoicing, and ultimately enabling their growth through solutions that are unique in the market,” said Pascal Houillon, CEO of Cegid.

With a track-record of sustained growth, EBP will find in Cegid and its majority shareholder Silver Lake a major ally to finance and structure its next phase of expansion, notably accelerating the transition to SaaS and the integration of generative artificial intelligence technology to better serve current and future clients.

“As a shareholder, Silver Lake is very pleased to continue promoting Cegid’s development. The growth potential of the small business software market is significant in Europe as a whole, and particularly in France where the introduction of electronic invoicing for all businesses is imminent. With the addition of EBP, we are accelerating Cegid's strategy in the Micro and SMB markets across the continent while starting a new phase of sustainable growth over the next decade. The quality of EBP's solutions combined with Cegid's footprint among chartered accountants make for a perfect combination in this high-potential market,” said Christian Lucas, Managing Partner of Silver Lake and Vice-Chairman of Cegid Group’s Board of Directors.

Founder René Sentis, Deputy Chief Executive Officer Grégoire Leclercq and his management team as well as EBP's 650 employees will join Cegid in the coming weeks.

“The timing of this combination could not be better for EBP's development. With nearly 40 years of significant growth, and now more motivated than ever to support our customers in their digital transformation journey and to prepare for the upcoming e-invoicing regulation, we are thrilled to be joining forces with Cegid. The company's strength, its expertise in cloud technologies, its recent announcements around offering a free PDP solution and the Cegid Business solution as part of the e-invoicing, as well as its investments in artificial intelligence will all be instrumental for EBP. Synergies resulting from this combination are evident with respect to both our product portfolios and Cegid’s footprint with CPAs, as well as financing solutions that we can offer to our clients – our conviction in this partnership is unwavering, and we are committed to reinvesting significantly in this combined group. Additionally, this is a great opportunity to accelerate the development of EBP’s recently launched Hubbix platform. With Cegid, we are proud to embark on this exciting journey to better serve our clients and conquer new markets together,” concludes René Sentis, Founder & CEO of EBP.

As is customary, the transaction remains subject to the approval of relevant regulatory authorities and to the information and consultation processes of representative bodies of staff concerned, in accordance with applicable laws.

More information:

About Cegid

Cegid is a European leader in cloud business management solutions for finance (cash-flow, tax, ERP), human resources (payroll, talent management), CPAs, retail and entrepreneurial sectors. With a solid full cloud business model, Cegid provides long-term commitment to its customers, superior and distinctive experiences and helps companies of all sizes accelerate their digital business transformation, locally and worldwide. Cegid combines a forward-thinking and pragmatic approach of the business with strong capacity to innovate, an in-depth expertise in new technologies such as artificial intelligence and an understanding of regulations and compliance. In today’s rapidly changing world, Cegid makes more possible by helping customers unleash their potential thanks to innovative and purposeful business solutions.

Bolstered by its strong international ambition and reach, and its 500,000 customers, Cegid has 4,400 employees and sells its solutions in 130 countries. Cegid reported revenues of €852 million (as of December 31 2023). Pascal Houillon has been the CEO since March 2017.

For more information: www.cegid.com/en/

About EBP

For 40 years, EBP supports the success and longevity of 275 000 Micro and SMBs, maintaining relationships founded on trust. The company offers solutions across France, Spain, Switzerland, Morocco and Ivory Coast, leveraging its extensive portfolio of innovative accounting, business management, HCM and CRM products tailored to SMBs, freelancers, retailers and independent professionals.

More information: EBP • Logiciels et solutions de gestion et de comptabilité and social networks

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240424304702/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye